Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Benitec Biopharma Q2 EPS $(2.64) Up From $(3.34) YoY

Author: Happy Mohamed | February 13, 2024 09:06am
Benitec Biopharma (NASDAQ:BNTC) reported quarterly losses of $(2.64) per share. This is a 20.96 percent increase over losses of $(3.34) per share from the same period last year.

Posted In: BNTC


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist